Goal-Directed Fluid Therapy for Thoracoscopic Lobectomy

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

January 25, 2025

Conditions
Thoracoscopic LobectomyThoracic AnesthesiaEnhanced Recovery After AnesthesiaLung Cancer
Interventions
OTHER

Goal-Directed Fluid Therapy (GDFT)

This arm administers fluid and vasopressor therapy based on SVV (less than 15%) and CI (\>2.6 L/min/m²) targets using the Pressure Recording Analytical Method (PRAM) system with the help of intra-arterial pressure monitoring method. Basal fluid replacement is provided with 5 mL/kg/hr of Lactated Ringer's solution.

OTHER

Conventional Fluid Therapy

This arm administers fluid and vasopressor therapy based on targets of Mean Arterial Pressure (MAP) 65-95 mmHg and hourly urine output minimum of 0.5 mL/kg/hr. Basal fluid replacement is provided with 5 mL/kg/hr of Lactated Ringer's solution.

Trial Locations (1)

01330

Cukurova University, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT07050979 - Goal-Directed Fluid Therapy for Thoracoscopic Lobectomy | Biotech Hunter | Biotech Hunter